On the basis of these findings, we hypothesized that elevated pHis, via downregulation of the histidine phosphatase LHPP and upregulation of the histidine kinases NME1 and NME2, contributes to disease progression in IBD patients. Here, NME2 is linked to inflammatory bowel disease.